1McCoy S, Blayney-Chandramouli J, Mutnick A. Using multiple pharmacoeconomic methods to conduct a cost-effectiveness analysis of histamine H2-receptor antagonists. Am J Health Syst Pharm,1998,55(24 suppl 4) :S58-S12.
2Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis.Drugs, 1997,54:581-596.
3Schumock GT, Lam NP, Winkler SR, et al. Pharmacoeconomic analysis of stress ulcer prophylaxis for critically ill patients. Pharmacoeconomics, 1996,9:455-465.
5Zhang J F,Zheng F.The role of paraventricular nucleus of hypothalamus in stress ulcer formation in rats[J].Brain Res,1997,761(2):203-209.
6Kauffman G L.Stress,the brain,and the gastric mucosa[J].Am J Surg,1997,174(3):271-275.
7Battal M N,Hata Y,Ito D,et al.Reduction of burn-induced gastric mucosal injury by an endothelin receptor antagonist in rats[J].Burns,1997,23(4):295-299.
8Suzuki H,Miura S,Imaeda H.Enhanced levels of chemiluminescence and platelet activating factor in urease-positive gastric ulcers[J].Free Radic Biol Med,1996,20(3):449-454.
9Wang H,Tan X,Chang H.Platelet-activating factor receptor mRNA is localized in eosinophils and epithelial cells in rat small intestine:regulation by dexamethasone and gut flora[J].Immunology,1999,97(3):447-454.
10Filaretov A A,Filaretova L P,Bogdanov A I,et al.The adaptation-protective effect of corticosteroids on the rat gastric mucosa and its mechanism[J].Fiziol Zh Im I M Sechenova,1996,82(3):141-150.
